Glycosaminoglycans

plasminogen ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 27976897 Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics. 2017 Jan 26 2
2 27301418 Plasmin and regulators of plasmin activity control the migratory capacity and adhesion of human T cells and dendritic cells by regulating cleavage of the chemokine CCL21. 2016 Nov 1
3 27564657 Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules. 2016 Oct 1
4 25937317 Exploitation of plasmin(ogen) by bacterial pathogens of veterinary significance. 2015 Jul 9 1
5 24659483 Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders. 2014 Nov 1
6 15203110 Identification of heparin affin regulatory peptide domains with potential role on angiogenesis. 2004 Oct 1
7 15613921 Effects of histidine-proline-rich glycoprotein on plasminogen activation in solution and on surfaces. 2004 Oct 6
8 11776053 Basic and clinical study on the antithrombotic mechanism of glycosaminoglycan extracted from sea cucumber. 2000 Aug 2
9 7561447 Endothelial cell injury induced by plasmin in vitro. 1995 Oct 1
10 1376317 Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation. 1992 Jun 15 2
11 1720904 Limited proteolysis of vitronectin by plasmin destroys heparin binding activity. 1991 Sep 2 2
12 6448845 The binding of low molecular weight heparin to hemostatic enzymes. 1980 Nov 10 1
13 6448846 The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. 1980 Nov 10 2
14 70942 [Histochemical studies on the content of plasmin in the normal and hyperplastic prostate (author's transl)]. 1977 1